最新凹凸永久免费视频_亚洲A级理论片在线观看_免费va不卡国产高清大片在线_亚洲日韩A∨电影天堂另类

【CGTN】The world's first COVID-19 inactivated vaccine production plant qualified to put into mass production
發(fā)布時間:2020-08-05

Pictures from China Biotech Group

A vaccine factory in China has qualified to mass produce a COVID-19 vaccine.

In a press release on Wednesday, China National Biotec Group said that in mid-July its world's first inactivated COVID-19 vaccine production plant in Beijing passed joint biosafety inspections organized by relevant departments, and is qualified to put a vaccine into mass production at any time.

Previously, the production facility had obtained a COVID-19 vaccine production license.


Picture from China Biotech Group

China National Biotec Group claims that this high-level biosafety production facility is currently the world's first, and the largest production plant for COVID-19 inactivated vaccines.

From design to construction, the workshop follows the relevant biosafety regulations and standards of China and the World Health Organization, and introduces experienced design teams from China and abroad. From building to maintaining, the production is in accordance with the high-level biosafety protection standard. The construction of the plant took only 2 months, and the construction was completed on April 15, 2020.

The construction of the high-level biosafety facilities and supporting laboratory complex of the Wuhan Institute of Biological Products of China National Biotech was completed on July 1. It strives to obtain relevant inspections and have production conditions as soon as possible.


Picture from China Biotech Group

The company says that China Biotech Group-Wuhan Institute of Biological Products will also become the world's only biological product R&D and production unit with a high-level biosafety R&D laboratory and production facility complex.

After the production plants of the two research institutes in Beijing and Wuhan are put into use, they will be able to guarantee that the annual production capacity of the COVID-19 inactivated vaccine will reach 220 million doses.

地址:北京市海淀區(qū)知春路20號 中國醫(yī)藥大廈

郵編:100191

電話:86-10-82287727

傳真:86-10-62033332

版權(quán)所有:國藥集團(tuán)

京公網(wǎng)安備 11040102700104號

京ICP備:14023670號-1
【CGTN】The world's first COVID-19 inactivated vaccine production plant qualified to put into mass production
發(fā)布時間:2020-08-05

Pictures from China Biotech Group

A vaccine factory in China has qualified to mass produce a COVID-19 vaccine.

In a press release on Wednesday, China National Biotec Group said that in mid-July its world's first inactivated COVID-19 vaccine production plant in Beijing passed joint biosafety inspections organized by relevant departments, and is qualified to put a vaccine into mass production at any time.

Previously, the production facility had obtained a COVID-19 vaccine production license.


Picture from China Biotech Group

China National Biotec Group claims that this high-level biosafety production facility is currently the world's first, and the largest production plant for COVID-19 inactivated vaccines.

From design to construction, the workshop follows the relevant biosafety regulations and standards of China and the World Health Organization, and introduces experienced design teams from China and abroad. From building to maintaining, the production is in accordance with the high-level biosafety protection standard. The construction of the plant took only 2 months, and the construction was completed on April 15, 2020.

The construction of the high-level biosafety facilities and supporting laboratory complex of the Wuhan Institute of Biological Products of China National Biotech was completed on July 1. It strives to obtain relevant inspections and have production conditions as soon as possible.


Picture from China Biotech Group

The company says that China Biotech Group-Wuhan Institute of Biological Products will also become the world's only biological product R&D and production unit with a high-level biosafety R&D laboratory and production facility complex.

After the production plants of the two research institutes in Beijing and Wuhan are put into use, they will be able to guarantee that the annual production capacity of the COVID-19 inactivated vaccine will reach 220 million doses.

地址:北京市海淀區(qū)知春路20號 中國醫(yī)藥大廈

郵編:100191 電話:86-10-82287727

傳真:86-10-62033332

版權(quán)所有:國藥集團(tuán)